
    
      This study is designed to prospectively collect blood samples and clinical data from subjects
      that have a suspected advanced adenoma or have been newly diagnosed with CRC scheduled for
      resection surgery, as well as subjects who are at average-risk of colorectal cancer and who
      are scheduled for routine colonoscopy examination.

      Subjects interested in participation and who meet inclusion criteria and provide written
      informed consent will be enrolled in the study. By accepting participation in the study,
      subjects will consent to provide up to 40 ml of blood at the study visit.
    
  